secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001493152-23-008197
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience to acquire Wisconsin Fertility Institute for $10M
-----------------------------------------------------------------

- Purchase price of $10M payable in four $2.5M installments; sellers may elect stock at $6.25, $9.09, $14.29 per share.
- Acquired clinic (WFRSA and FLOW) had FY2021 revenue of $5.7M and net income of $2.3M.
- Asset Purchase Agreement covers non-medical assets of WFRSA; Membership Interest Purchase Agreement for 100% of FLOW.
- Closing expected in Q2 2023; subject to customary conditions.
- Management services agreement will outsource all non-medical activities to Buyer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223008197/0001493152-23-008197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223008197/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer